[Tree] Establishment of Bharat FDA for global pharmaceutical standards

Version 0.3 (2024-11-23 12:49:47.567000)

updates: Sitharaman's proposals at India Ideas Conclave

  • ➔
Version 0.29 (2024-11-23 08:54:17.400000)

updates: Introduction of Bharat FDA proposal by FM Sitharaman

  • ➔
  • ➔
  • ➔
Version 0.28 (2024-07-23 08:04:01.443000)

updates: Changes in customs duties proposed in Union Budget 2024-25

  • ➔
  • ➔
Version 0.27 (2024-07-12 03:54:04.076000)

updates: Add information about the federal grant received by the Mashantucket Pequot Tribal Nation for pharmaceutical manufacturing

  • ➔
  • ➔
Version 0.26 (2024-07-10 09:56:51.634000)

updates: Generic drug manufacturing by Mashantucket Pequot Tribal Nation in Connecticut

  • ➔
  • ➔
Version 0.25 (2024-07-06 08:55:55.185000)

updates: Indian pharmaceutical industry seeks tax relief and financial support in Union Budget 2024

  • ➔
Version 0.24 (2024-06-25 12:55:05.170000)

updates: Biocon's market share growth in the US for biosimilars

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.23 (2024-06-25 08:55:32.503000)

updates: Jubilant Pharmova repays term loan, improves debt-to-EBITDA ratio

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.22 (2024-06-23 06:53:56.741000)

updates: Lupin and Eugia recall products from US market due to manufacturing issues

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.21 (2024-06-15 11:59:44.748000)

updates: Biocon's Visakhapatnam API facility receives 3 USFDA observations

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.2 (2024-05-28 06:53:46.842000)

updates: Includes Strides Pharma's Q4 results and performance

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.19 (2024-05-28 03:56:59.374000)

updates: Aurobindo Pharma reports strong Q4 results and growth outlook

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.18 (2024-05-27 10:54:47.636000)

updates: Indian drugmakers expected to see revenue boost in the US market due to drug shortages

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.17 (2024-05-23 06:56:36.663000)

updates: Analyst expects 15-18% upside in Sun Pharma stock

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.16 (2024-05-23 04:57:48.656000)

updates: Sun Pharma's Q4 results show steady growth in India and strong growth in the US in Q4

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.15 (2024-05-10 04:54:33.106000)

updates: Inclusion of Alembic Pharma's Q4 results and growth drivers

  • ➔
  • ➔
  • ➔
Version 0.14 (2024-04-20 12:20:49.214000)

updates: Q4 earnings boost from US market, surge in pharmaceutical exports to the United States

  • ➔
  • ➔
Version 0.13 (2024-04-13 06:21:33.291000)

updates: Updated Q4 earnings preview and recommendations

  • ➔
Version 0.12 (2024-04-12 03:30:51.251000)

updates: Updates on India's pharmaceutical industry Q4 earnings

  • ➔
Version 0.11 (2024-04-11 07:19:05.973000)

updates: CII President R Dinesh foresees GDP growth at 8-9% amid global challenges

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.1 (2024-03-31 21:18:44.500000)

updates: Updated information on India's GDP growth and macro-indicators

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.09 (2024-03-30 23:19:10.108000)

updates: Finance Minister Nirmala Sitharaman anticipates GDP growth of 8% or higher for the March quarter. She credits India's energetic population for the economic growth and addresses the surge in income tax notices due to digitization and compliance requirements.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.08 (2024-03-30 14:22:57.772000)

updates: India's GDP growth projection for Jan-March quarter

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.07 (2024-03-23 15:25:30.902000)

updates: Information about India's gaming industry and the Game Developers Conference in the US

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2024-03-05 07:20:28.608000)

updates: Inclusion of information about GVA's expansion plans [f2c4edd3]

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-01-09 08:21:40.271000)

updates: Added information about the value retail market in India

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.05 (2024-01-09 08:21:40.271000)

updates: Added information about the value retail market in India

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.04 (2024-01-03 00:10:02.797000)

updates: Integration of information about India's malls forecasted to expand by 116-118 million square feet by 2025

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.03 (2023-12-31 00:08:54.578000)

updates: Updates on Mumbai's real estate market and property registrations

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.02 (2023-12-30 09:05:00.790000)

updates: Inclusion of information about Mumbai's property market surge in sales

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-12-02 06:44:48.078000)

updates: The construction sector's contribution to GDP growth

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.0 (2023-12-02 05:34:40.889000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔